Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Summary of Stock Option Activities (Details)

v3.22.1
Stock-Based Compensation - Summary of Stock Option Activities (Details) - Options - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Options      
Outstanding - beginning balance (in shares) 8,084,676    
Granted (in shares) 0    
Exercised (in shares) (115,103)    
Forfeited (in shares) 0    
Outstanding - ending balance (in shares) 7,969,573    
Exercisable at period end (in shares) 7,969,573    
Weighted Average Exercise Price      
Outstanding - beginning balance (in dollars per share) $ 0.19    
Granted (in dollars per share) 0    
Exercised (in dollars per share) 0.18    
Forfeited (in dollars per share) 0    
Outstanding - ending balance (in dollars per share) 0.19    
Exercisable at period end (in dollars per share) 0.19    
Weighted Average Grant Date Fair Value      
Outstanding - beginning balance (in dollars per share) 0.21    
Granted (in dollars per share) 0    
Exercised (in dollars per share) 0.34    
Forfeited (in dollars per share) 0    
Outstanding - ending balance (in dollars per share) 0.21    
Exercisable at period end (in dollars per share) $ 0.21    
Additional Disclosures      
Weighted Average Remaining Life (years) 5 years 3 months 18 days 5 years 7 months 6 days  
Weighted Average Remaining Life, Exercisable (years) 5 years 3 months 18 days    
Intrinsic Value $ 67,126   $ 69,875
Intrinsic Value, Exercisable $ 67,126